PT1042314E - Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos - Google Patents

Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos

Info

Publication number
PT1042314E
PT1042314E PT98962044T PT98962044T PT1042314E PT 1042314 E PT1042314 E PT 1042314E PT 98962044 T PT98962044 T PT 98962044T PT 98962044 T PT98962044 T PT 98962044T PT 1042314 E PT1042314 E PT 1042314E
Authority
PT
Portugal
Prior art keywords
enantiomerically enriched
oxides
hydrobenzotiepe
tetra
preparation
Prior art date
Application number
PT98962044T
Other languages
English (en)
Inventor
David B Reitz
James Li
Ching-Cheng Wang
Victor Snieckus
Horng-Chih Huang
Andrew J Carpenter
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of PT1042314E publication Critical patent/PT1042314E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PT98962044T 1997-12-19 1998-12-16 Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos PT1042314E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6817097P 1997-12-19 1997-12-19

Publications (1)

Publication Number Publication Date
PT1042314E true PT1042314E (pt) 2003-07-31

Family

ID=22080853

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98962044T PT1042314E (pt) 1997-12-19 1998-12-16 Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos

Country Status (19)

Country Link
US (2) US6369220B1 (pt)
EP (1) EP1042314B1 (pt)
JP (1) JP2001526284A (pt)
KR (1) KR20010015884A (pt)
CN (2) CN1106395C (pt)
AT (1) ATE234829T1 (pt)
AU (1) AU1721399A (pt)
BR (1) BR9814300A (pt)
DE (1) DE69812419T2 (pt)
DK (1) DK1042314T3 (pt)
ES (1) ES2195428T3 (pt)
HK (1) HK1034971A1 (pt)
HU (1) HUP0101193A3 (pt)
IL (1) IL136864A (pt)
PT (1) PT1042314E (pt)
RU (1) RU2236406C2 (pt)
UA (1) UA67764C2 (pt)
WO (1) WO1999032478A1 (pt)
ZA (1) ZA9811648B (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
JP2003528830A (ja) 2000-03-10 2003-09-30 ファルマシア・コーポレーション テトラヒドロベンゾチエピン類の製造方法
EG26979A (en) 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
JP3616635B2 (ja) 2001-09-08 2005-02-02 アストラゼネカ アクチボラグ 高脂質血症の治療のための回腸胆汁酸運搬(ibat)阻害活性を持つベンゾチアゼピン及びベンゾチアジアゼピン誘導体
MXPA04003524A (es) * 2001-11-02 2004-07-23 Searle Llc Compuestos de benzotiepina monofluorados y difluorados novedosos como inhibidores de transporte de acido biliar co-dependiente de sodio apical (asbt) y captacion de taurocolato.
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
GB0213669D0 (en) 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0304194D0 (en) 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP1719768B1 (en) 2004-02-27 2012-04-25 Asahi Kasei Pharma Corporation Novel benzothiazepine and benzothiepine compounds
WO2010062861A2 (en) 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
RU2619215C2 (ru) 2010-11-08 2017-05-12 Альбирео Аб Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты
CN103260625B (zh) 2010-11-08 2016-01-06 阿尔比里奥公司 用于治疗肝脏疾病的ibat抑制剂
CN102558250B (zh) * 2010-12-14 2015-01-14 王芃 一种艾杜糖醛酸及其衍生物的制备方法
CA2853285C (en) 2011-10-28 2020-05-05 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
KR102051031B1 (ko) 2011-10-28 2019-12-02 루메나 파마수티컬즈, 인코포레이티드 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
WO2014145251A1 (en) 2013-03-15 2014-09-18 Georgetown University Determining stereoisomeric excess, concentration and absolute configuration
EP2968230A2 (en) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
KR20160003664A (ko) 2013-03-15 2016-01-11 루메나 파마수티컬즈, 인코포레이티드 바렛 식도 및 위식도 역류 질환 치료용 담즙산 재순환 억제제
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
KR102560954B1 (ko) 2014-06-25 2023-07-31 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
ES2874546T3 (es) 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
CA3011565C (en) 2016-02-09 2024-01-02 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
EP3664781A1 (en) 2017-08-09 2020-06-17 Albireo AB Cholestyramine granules, oral cholestyramine formulations and use thereof
CN110996915B (zh) 2017-08-09 2023-10-03 阿尔比里奥公司 考来烯胺丸粒、口服考来烯胺制剂及其用途
TW202015699A (zh) 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
WO2020056012A1 (en) 2018-09-11 2020-03-19 Georgetown University Quantitative auxiliary-free chirality sensing with a metal probe
CN109516971B (zh) * 2018-11-26 2020-09-25 山东永浩新材料科技有限公司 一种电池级硫酸乙烯酯的合成方法
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
AU2020221834A1 (en) 2019-02-12 2021-09-02 Mirum Pharmaceuticals, Inc. Genotype and dose-dependent response to an ASBTI in patients with bile salt export pump deficiency
CA3158276A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
EP4069360B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4069247A1 (en) 2019-12-04 2022-10-12 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
CN116157389A (zh) 2020-08-03 2023-05-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
CN116583504A (zh) 2020-12-04 2023-08-11 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US20240116891A1 (en) * 2022-09-14 2024-04-11 Mirum Pharmaceuticals, Inc. Maralixibat solid forms, intermediates and processes of making same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59144777A (ja) 1983-02-04 1984-08-18 Tokawa Tetsuo ベンゾチアゼピン誘導体の光学分割法
US5559017A (en) 1989-08-09 1996-09-24 E. R. Squibb & Sons, Inc. Microbial reduction of benzazepines and benzothiazepine derivatives
IT1249318B (it) 1991-05-23 1995-02-22 Zambon Spa Processo per la preparazione di benzotiazepine per ciclizzazione con acidi fosfonici
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
CA2199944A1 (en) * 1994-09-13 1996-03-21 Len Fang Lee Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
EP0888333B1 (en) 1996-03-11 2005-08-31 G.D. Searle LLC Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake

Also Published As

Publication number Publication date
DE69812419D1 (de) 2003-04-24
DE69812419T2 (de) 2003-08-14
ZA9811648B (en) 1999-12-20
IL136864A (en) 2004-07-25
US6369220B1 (en) 2002-04-09
RU2236406C2 (ru) 2004-09-20
CN1106395C (zh) 2003-04-23
HK1034971A1 (en) 2001-11-09
US20020188119A1 (en) 2002-12-12
EP1042314A1 (en) 2000-10-11
UA67764C2 (uk) 2004-07-15
CN1439638A (zh) 2003-09-03
WO1999032478A1 (en) 1999-07-01
AU1721399A (en) 1999-07-12
KR20010015884A (ko) 2001-02-26
BR9814300A (pt) 2002-02-05
IL136864A0 (en) 2001-06-14
ES2195428T3 (es) 2003-12-01
HUP0101193A3 (en) 2001-12-28
DK1042314T3 (da) 2003-07-14
ATE234829T1 (de) 2003-04-15
HUP0101193A2 (hu) 2001-08-28
US6875877B2 (en) 2005-04-05
EP1042314B1 (en) 2003-03-19
JP2001526284A (ja) 2001-12-18
CN1284953A (zh) 2001-02-21

Similar Documents

Publication Publication Date Title
PT1042314E (pt) Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos
DE3778343D1 (de) Verborgene praeambel zur frequenzsprungsynchronisation.
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
NO20016226D0 (no) Fremgangsmåte for fremstilling av substituerte formamider
BG102474A (en) (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate
ATE227723T1 (de) Eintopfverfahren zur herstellung von 2- oxazolidinonderivate
ATA1285A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
DK0378455T3 (da) Fremgangsmåde til fremstilling af derivater af (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiazepine-4-on
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
ES2019652B3 (es) Procedimiento catalitico de produccion de mercaptanos a partir de tioesteres.
IS2201B (is) Aðferð til framleiðslu á handhverfu auðguðum N-afleiddum laktömum
BR9711803A (pt) Processo aperfei-oado para a prepara-Æo de clavulanato de pot ssio
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
KR920701470A (ko) 라세미 기질의 효소적 가수분해를 통한 항균성 중간물질의 제조방법
DE69510798D1 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
ATA278985A (de) Verfahren zur herstellung von cephalosporinderivaten
KR870700627A (ko) 세팔로스포린 유도체의 신규 제조방법
NO307919B1 (no) FremgangsmÕte for fremstilling av et bulbjern, samt bulbjern
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
DK0688737T3 (da) Fremgangsmåde til fremstilling af hvidt carbon
DE69529514D1 (de) Verfahren zur herstellung von (r)-2-amino-1-phenylethanol oder seinen halogenierten derivaten, verfahren zur herstellung von optisch aktivem phenylserin und seinen halogenierten derivaten, und die neuartige verbindung 3-(3-chlorophenyl)serin
DK0389876T3 (da) Hidtil ukendt fremgangsmåde til syntese af N-methyl-3,4-dimethoxyphenylethylamin
ATA244087A (de) Verfahren zur herstellung von neuen cephalosporin-verbindungen
CS381488A1 (en) Method of racemic d,1-lobeline production
CS381388A1 (en) Method of racemic d,1-lobeline production